{"id":"W2977583264","doi":"10.14309/00000434-200910003-01105","title":"Improvement in Work Productivity and Daily Activities by Certolizumab Pegol in Crohnʼs Disease Patients with Prior Loss of Response or Intolerance to Infliximab","year":2009,"lang":"en","type":"article","venue":"The American Journal of Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Certolizumab pegol; Medicine; Infliximab; Internal medicine; Physical therapy; Dosing; Randomized controlled trial; Adalimumab; Placebo; Surgery; Tumor necrosis factor alpha; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001506742,0.0003420543,0.001170293,0.000298631,0.0003397203,0.0003758037,0.0002116939,0.0003747929,0.001068752],"category_scores_gemma":[0.001496714,0.0001744304,0.0005234483,0.0003686408,0.0003443688,0.0002858385,0.0002445924,0.0004869711,0.000190517],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003080081,"about_ca_system_score_gemma":0.0002670402,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003877453,"about_ca_topic_score_gemma":0.0008263462,"domain_scores_codex":[0.9995473,0.0002098459,0.00005671108,0.00005494225,0.00006945325,0.00006173166],"domain_scores_gemma":[0.9994997,0.0001518691,0.0001544162,0.00002858367,0.00003205664,0.0001333811],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3196399,0.01156095,0.4316406,0.001003428,0.001192776,0.0009310316,0.0004839922,0.0008810686,0.02114079,0.00004799032,0.001002106,0.2104755],"study_design_scores_gemma":[0.03217012,0.1351163,0.8258556,0.00008596591,0.0004694079,0.001356433,0.000159074,0.0008411282,0.002263021,0.00006632783,0.001590851,0.0000257344],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985441,0.001082888,0.00004361209,0.00004560276,0.00001334436,0.00003408597,0.00002740847,0.000003163741,0.0002058605],"genre_scores_gemma":[0.999238,0.0002906189,0.0001103615,0.00005116727,0.00002270345,0.00004046653,0.00009720458,8.383611e-7,0.0001484812],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001506742,"threshold_uncertainty_score":0.007968545,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.002733529320174296,"score_gpt":0.215343252388648,"score_spread":0.2126097230684738,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}